PATENT CLAIM ANALYSIS

Application Number: 16068593
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "282000"]

Abstract:
Disclosed is a method for reducing or preventing fetal opioid dependence in a drug dependent or opioid tolerant pregnant subject. The method involves administering to the pregnant subject a composition comprising an opioid antagonist in an amount effective to reduce or prevent fetal opioid dependence, wherein the opioid antagonist a) is orally available or delivered systemically and reaches the circulation of the pregnant subject, b) is substantially excluded from the subject's brain by the blood brain barrier, and c) penetrates the placenta and enters the fetal brain. The method also includes administering the opioid antagonist to the neonate in increasing amounts to facilitate weaning the neonate from continued opioid maintenance.

Claim (Index 17):
The method of  claim 12 , wherein the opioid antagonist is delivered in a daily dosage range from about 0.1 mg to about 100 mg.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14278576', '13687683', '12288347', '11820499', '13371760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8156954580815293
- 35 USC 102 Novelty (BERT): 0.5180669651344081
- Combined Prediction Score: 0.7859326087868173
- Mean Citation Score: 278.350878
- Max Citation Score: 312.225
- Similarity Product: 219.80280706733467

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test